RDIF: Sputnik V’s Efficacy at 97.6% Based on Data Analysis of 3.8 Mln Vaccinated Russians

Apr 19, 2021 | EARNINGS

MOSCOW (Sputnik) – The efficacy of the Russian coronavirus vaccine Sputnik V reached 97.6 percent, based on the analysis of data pertaining to post-vaccination infection percentage among vaccinated Russians, the Gamaleya National Research Centre of Epidemiology and Microbiology and the Russian Direct Investment Fund (RDIF) announced on Monday.

Read More

Pin It on Pinterest